FDA reviewing safety data regarding possible risk for cancer in patient with diabetes.
Lantus (insulin glargine)
July 1st, 2009 · No Comments
Tags: FDA · FDA Alerts
FDA reviewing safety data regarding possible risk for cancer in patient with diabetes.
Tags: FDA · FDA Alerts
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.